Omega Therapeutics, Inc.
OMGADelisted Mar 20, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850838
Omega Therapeutics, Inc. was delisted on Mar 20, 2025; its insiders filed their last Form 4 on Dec 5, 2024; 53 institutions reported holding it in 13F filings for Q4 2024, worth $35.3M in total; no superinvestor held it.
Q2 2025 vs. Q1 2025
How the institutions holding Omega Therapeutics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 4 | 1 | −3 |
| Shares | 19.6K | 1 | −19.6K (−100.0%) |
| Value | $2.50K | $0 | −$2.50K (−100.0%) |
New holders (0)
Institutions that held Omega Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
None.
Sold out (3)
Institutions that held Omega Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Barclays PLC | 13,278 | $1.08K |
| Principal Securities, Inc. | 1,370 | $1.02K |
| Steward Partners Investment Advisory, LLC | 5,000 | $405 |